Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Buy
106,935
+18,663
+21% +$2.15M 0.06% 162
2025
Q4
$9.29M Buy
88,272
+4,784
+6% +$449K 0.05% 183
2025
Q3
$7.01M Buy
83,488
+1,247
+2% +$103K 0.04% 200
2025
Q2
$6.51M Buy
82,241
+3,812
+5% +$303K 0.05% 188
2025
Q1
$7.04M Sell
78,429
-75,080
-49% -$7.01M 0.06% 169
2024
Q4
$15.3M Buy
153,509
+17,351
+13% +$1.79M 0.12% 111
2024
Q3
$15.5M Buy
136,158
+22,118
+19% +$2.63M 0.13% 113
2024
Q2
$14.1M Sell
114,040
-5,711
-5% -$736K 0.14% 111
2024
Q1
$15.8M Buy
119,751
+4,102
+4% +$506K 0.18% 95
2023
Q4
$12.6M Buy
115,649
+3,641
+3% +$378K 0.16% 103
2023
Q3
$11.5M Buy
112,008
+5,920
+6% +$638K 0.17% 106
2023
Q2
$12.2M Buy
106,088
+54,868
+107% +$6.23M 0.19% 96
2023
Q1
$5.45M Buy
51,220
+4,981
+11% +$538K 0.1% 135
2022
Q4
$4.48M Buy
46,239
+8,085
+21% +$826K 0.11% 101
2022
Q3
$3.29M Sell
38,154
-294
-0.8% -$26.2K 0.1% 112
2022
Q2
$3.5M Buy
38,448
+4,424
+13% +$392K 0.11% 104
2022
Q1
$2.79M Buy
34,024
+1,526
+5% +$120K 0.09% 121
2021
Q4
$2.49M Buy
32,498
+760
+2% +$60.5K 0.08% 132
2021
Q3
$2.38M Sell
31,738
-2,144
-6% -$163K 0.09% 126
2021
Q2
$2.63M Sell
33,882
-1,426
-4% -$106K 0.11% 105
2021
Q1
$2.6M Sell
35,308
-1,248
-3% -$92.1K 0.14% 97
2020
Q4
$2.85M Buy
36,556
+1,974
+6% +$151K 0.17% 86
2020
Q3
$2.74M Sell
34,582
-1,312
-4% -$103K 0.19% 81
2020
Q2
$2.65M Buy
35,894
+192
+0.5% +$14.5K 0.2% 80
2020
Q1
$2.62M Buy
35,702
+10,140
+40% +$797K 0.25% 74
2019
Q4
$2.22M Buy
25,562
+783
+3% +$64.3K 0.27% 85
2019
Q3
$1.99M Buy
24,779
+1,601
+7% +$128K 0.28% 80
2019
Q2
$1.85M Sell
23,178
-134
-0.6% -$10.3K 0.26% 80
2019
Q1
$1.85M Buy
23,312
+270
+1% +$20.2K 0.35% 63
2018
Q4
$1.68M Buy
23,042
+2,666
+13% +$188K 0.35% 63
2018
Q3
$1.38M Buy
20,376
+134
+0.7% +$8.54K 0.25% 78
2018
Q2
$1.17M Buy
20,242
+44
+0.2% +$2.48K 0.25% 76
2018
Q1
$1.05M Buy
20,198
+769
+4% +$41.5K 0.22% 80
2017
Q4
$1.04M Buy
19,429
+174
+0.9% +$9.65K 0.22% 84
2017
Q3
$1.18M Buy
19,255
+125
+0.7% +$7.58K 0.26% 65
2017
Q2
$1.17M Sell
19,130
-1,689
-8% -$103K 0.28% 65
2017
Q1
$1.26M Buy
20,819
+1,495
+8% +$90.7K 0.31% 59
2016
Q4
$1.08M Sell
19,324
-6
-0% -$351 0.29% 61
2016
Q3
$1.15M Buy
19,330
+21
+0.1% +$1.23K 0.32% 53
2016
Q2
$1.06M Buy
19,309
+599
+3% +$31.9K 0.3% 53
2016
Q1
$945K Sell
18,710
-975
-5% -$47.8K 0.29% 58
2015
Q4
$992K Buy
19,685
+4,690
+31% +$236K 0.31% 52
2015
Q3
$707K Sell
14,995
-31
-0.2% -$1.65K 0.25% 67
2015
Q2
$816K Sell
15,026
-285
-2% -$16K 0.27% 64
2015
Q1
$840K Buy
15,311
+3,705
+32% +$210K 0.3% 62
2014
Q4
$629K Buy
11,606
+53
+0.5% +$2.95K 0.24% 75
2014
Q3
$653K Buy
11,553
+3,424
+42% +$192K 0.28% 64
2014
Q2
$449K Hold
8,129
0.19% 88
2014
Q1
$440K Buy
8,129
+188
+2% +$9.73K 0.2% 86
2013
Q4
$379K Sell
7,941
-38
-0.5% -$1.74K 0.19% 92
2013
Q3
$362K Sell
7,979
-100
-1% -$4.57K 0.2% 86
2013
Q2
$358K Buy
+8,079
New +$361K 0.21% 82

Other funds holding MRK

Savant Capital's MRK Position: Q1 2026 in Review

Savant Capital increased its Merck (MRK) stake by 21% in Q1 2026, buying an estimated $2.15M and bringing the position to 106,935 shares worth $12.9M. The position accounts for 0.06% of the portfolio, ranked #162.

Savant Capital first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.8M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Savant Capital held 106,935 shares of Merck worth $12.9M as of Q1 2026.
  • Savant Capital bought 18,663 Merck shares in Q1 2026, an estimated $2.15M.
  • Merck made up 0.06% of Savant Capital's portfolio in Q1 2026, its #162 holding.
  • Savant Capital first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Savant Capital's Merck position peaked at $15.8M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.